Pharma · Private company
Shionogi
Track this companyFree. Adds Shionogi to your Dealase workspace and tells you when its record changes.
Clinical trials2510 recruiting or active
Pipeline programs22From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Pipeline22
- MT-1186Phase 3 · ALSClinicalTrials.gov · fetched Nov 12, 2026
- MT-1186Phase 3 · Amyotrophic Lateral Sclerosis (ALS)ClinicalTrials.gov · fetched Nov 12, 2026
- S-217622Phase 3 · SARS-CoV-2 InfectionClinicalTrials.gov · fetched Nov 12, 2026
- SecutrelvirPhase 3 · SARS-CoV-2ClinicalTrials.gov · fetched Nov 12, 2026
- AcetazolamidePhase 2 · Sleep ApneaClinicalTrials.gov · fetched Nov 12, 2026
- BevacizumabPhase 2 · Solid TumorsClinicalTrials.gov · fetched Nov 12, 2026
- BPN14770Phase 2 · Jordan's SyndromeClinicalTrials.gov · fetched Nov 12, 2026
- CefiderocolPhase 2 · Gram-Negative Bacterial InfectionsClinicalTrials.gov · fetched Nov 12, 2026
- JTT-861 CapsulesPhase 2 · Chronic Heart FailureClinicalTrials.gov · fetched Nov 12, 2026
- PembrolizumabPhase 2 · Solid TumorsClinicalTrials.gov · fetched Nov 12, 2026
- RedasemtidePhase 2 · Acute Ischemic StrokeClinicalTrials.gov · fetched Nov 12, 2026
- S-337395Phase 2 · Respiratory Syncytial Virus InfectionsClinicalTrials.gov · fetched Nov 12, 2026
- S-531011Phase 2 · Solid TumorsClinicalTrials.gov · fetched Nov 12, 2026
- S-606001Phase 2 · Pompe DiseaseClinicalTrials.gov · fetched Nov 12, 2026
- S-892216Phase 2 · COVID-19ClinicalTrials.gov · fetched Nov 12, 2026
- SASS-001Phase 2 · Sleep ApneaClinicalTrials.gov · fetched Nov 12, 2026
- SivopixantPhase 2 · Sleep ApneaClinicalTrials.gov · fetched Nov 12, 2026
- BPN14770Phase 1 · Renal ImpairmentClinicalTrials.gov · fetched Nov 12, 2026
- S-892216-LAIPhase 1 · Healthy ParticipantsClinicalTrials.gov · fetched Nov 12, 2026
- S-892216-POPhase 1 · Renal ImpairmentClinicalTrials.gov · fetched Nov 12, 2026
- SulthiamePhase 1 · Renal ImpairmentClinicalTrials.gov · fetched Nov 12, 2026
- Edaravone (Radicava®/Radicava ORS®)Amyotrophic Lateral SclerosisClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials25
- Study of Sulthiame (S-054502) in Participants With Renal Impairment and Matched Healthy ControlsPHASE1 · NOT_YET_RECRUITING · started Sep 29, 2026ClinicalTrials.gov NCT07857837 · fetched Nov 12, 2026
- A Study of Secutrelvir in Participants With Coronavirus Disease 2019 (COVID-19) Who Are at High Risk for Progression to Severe DiseasePHASE3 · RECRUITING · started Sep 14, 2026ClinicalTrials.gov NCT07743580 · fetched Nov 12, 2026
- Pharmacokinetic Analysis of Cefiderocol in Patients With Acute Burn InjuriesPHASE4 · RECRUITING · started Feb 16, 2026ClinicalTrials.gov NCT07465432 · fetched Nov 12, 2026
- A Study of S-337395 in Symptomatic Nonhospitalized Adults With Respiratory Syncytial Virus (RSV) Who Are at High Risk of Progression to Severe DiseasePHASE2 · RECRUITING · started Dec 11, 2025ClinicalTrials.gov NCT07214571 · fetched Nov 12, 2026
- Study of S-606001 as an Add-on to Enzyme Replacement Therapy (ERT) in Participants With Late-onset Pompe Disease (LOPD)PHASE2 · RECRUITING · started Oct 30, 2025ClinicalTrials.gov NCT07123155 · fetched Nov 12, 2026
- A Study of S-892216-PO in Participants With Renal Impairment and Matched ControlsPHASE1 · COMPLETED · started Oct 16, 2025ClinicalTrials.gov NCT07217886 · fetched Nov 12, 2026
- A Study to Investigate Safety and Pharmacokinetics of Intravenous Cefiderocol/Xeruborbactam in Participants With Renal ImpairmentPHASE1 · COMPLETED · started Sep 16, 2025ClinicalTrials.gov NCT07104162 · fetched Nov 12, 2026
- Study of BPN14770 in Participants With Severe Renal Impairment and Healthy ControlsPHASE1 · COMPLETED · started Aug 25, 2025ClinicalTrials.gov NCT07012005 · fetched Nov 12, 2026
- Study of S-892216 Long-acting Injectable (LAI) in Healthy Adult ParticipantsPHASE1 · RECRUITING · started Jul 29, 2025ClinicalTrials.gov NCT07093580 · fetched Nov 12, 2026
- A Study of S-892216 in Participants With COVID-19PHASE2 · COMPLETED · started Jun 6, 2025ClinicalTrials.gov NCT06928051 · fetched Nov 12, 2026
- Study of Zatolmilast (BPN14770) in Participants With PPP2R5D Neurodevelopmental Disorder (Jordan's Syndrome [JS])PHASE2 · ACTIVE_NOT_RECRUITING · started May 13, 2025ClinicalTrials.gov NCT06717438 · fetched Nov 12, 2026
- Safety and Efficacy Study of Sivopixant, Acetazolamide and SASS-001 in Sleep ApneaPHASE2 · ACTIVE_NOT_RECRUITING · started Apr 2, 2025ClinicalTrials.gov NCT06776432 · fetched Nov 12, 2026
- Ensitrelvir for Viral Persistence and Inflammation in People Experiencing Long COVIDPHASE2 · ACTIVE_NOT_RECRUITING · started Apr 9, 2024ClinicalTrials.gov NCT06161688 · fetched Nov 12, 2026
- A Study to Assess the Safety, Tolerability, and Pharmacokinetics of Cefiderocol in Hospitalized Neonates and InfantsPHASE2 · COMPLETED · started Mar 14, 2024ClinicalTrials.gov NCT06086626 · fetched Nov 12, 2026
- Evaluate Efficacy, Safety and Tolerability of JTT-861 in Subjects With Heart Failure With Reduced Ejection FractionPHASE2 · COMPLETED · started Dec 20, 2023ClinicalTrials.gov NCT06017609 · fetched Nov 12, 2026
- A Phase 2b, Randomized, Double-blind Study of Redasemtide (S-005151) in Adult Participants With Acute Ischemic StrokePHASE2 · COMPLETED · started Jul 14, 2023ClinicalTrials.gov NCT05953480 · fetched Nov 12, 2026
- Phase 3 Study of S-217622 in Prevention of Symptomatic SARS-CoV-2 InfectionPHASE3 · COMPLETED · started Jun 9, 2023ClinicalTrials.gov NCT05897541 · fetched Nov 12, 2026
- A Study to Compare S-217622 With Placebo in Non-Hospitalized Participants With COVID-19PHASE3 · COMPLETED · started Aug 3, 2022ClinicalTrials.gov NCT05305547 · fetched Nov 12, 2026
- S-531011 as Monotherapy and in Combination With an Immune Checkpoint Inhibitor in Advanced or Metastatic Solid TumorsPHASE1_PHASE2 · RECRUITING · started May 30, 2022ClinicalTrials.gov NCT05101070 · fetched Nov 12, 2026
- Olorofim Aspergillus Infection StudyPHASE3 · COMPLETED · started Apr 29, 2022ClinicalTrials.gov NCT05101187 · fetched Nov 12, 2026
- Efficacy and Safety Extension Study of Oral Edaravone Administered in Subjects With ALSPHASE3 · TERMINATED · started Jan 11, 2022ClinicalTrials.gov NCT05151471 · fetched Nov 12, 2026
- Efficacy and Safety Study of Oral Edaravone Administered in Subjects With ALSPHASE3 · TERMINATED · started Nov 13, 2020ClinicalTrials.gov NCT04569084 · fetched Nov 12, 2026
- Safety Extension Study of Oral Edaravone Administered in Subjects With Amyotrophic Lateral Sclerosis (ALS)PHASE3 · COMPLETED · started Oct 29, 2020ClinicalTrials.gov NCT04577404 · fetched Nov 12, 2026
- Safety Study of Oral Edaravone Administered in Subjects With ALSPHASE3 · COMPLETED · started Nov 18, 2019ClinicalTrials.gov NCT04165824 · fetched Nov 12, 2026
- Radicava® (Edaravone) Findings in Biomarkers From ALS (REFINE-ALS)COMPLETED · started Oct 21, 2019ClinicalTrials.gov NCT04259255 · fetched Nov 12, 2026